G01N 33 - Investigating or analysing materials by specific methods not covered by groups

Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
11/2013
11/21/2013	WO2013171123A1 Sample holder with magnetic base and magnetisable body
11/21/2013	WO2013171015A1 Method and control unit for compensating a voltage offset in a two-point lambda probe
11/21/2013	WO2013170994A1 Marker sequences for rheumatoid arthritis
11/21/2013	WO2013170973A1 Moisture measurement device for concrete floors
11/21/2013	WO2013170960A1 Use of vegfr1 as a biomarker for pkn3 inhibitor administration
11/21/2013	WO2013170914A1 Polymer matrix with target binding site for creatinine and derivatives thereof, its preparation and uses
11/21/2013	WO2013170855A1 Method for the specific and quantitative detection of antibodies in a sample
11/21/2013	WO2013170369A1 Early predictive markers of pre-eclampsia
11/21/2013	WO2013170365A1 Compositions of sparc polypeptide and grp78, and methods and uses thereof for sensitizing cancer cells
11/21/2013	WO2013149258A3 Compositions and methods for treating or preventing metabolic syndrome disorders
11/21/2013	WO2013149171A3 Methods for increasing efficacy of cd37-based therapy
11/21/2013	WO2013138522A3 Methods for assessing effectiveness and monitoring oncolytic virus treatment
11/21/2013	WO2013134733A3 Biomarker sampling in the context of neuromodulation devices and associated systems
11/21/2013	WO2013132040A3 In vitro potency assay for protein-based meningococcal vaccines
11/21/2013	WO2013116513A3 Direct detection of disease biomarkers in clinical specimens using cationic nanoparticle-based assays & versatile and green methods forsynthesis of anisotropic silver nanostructures
11/21/2013	WO2013084074A3 Spectroscopic troponin i detection and quantification using plasmonic nano-materials
11/21/2013	WO2009139681A8 Treatment prediction involving hmgcr protein
11/21/2013	US20130310682 CSF Biomarker Dilution Factor Corrections by MRI Imaging and Algorithm
11/21/2013	US20130310672 Method of measuring bleeding volume
11/21/2013	US20130310546 Nucleophilic catalysts for oxime linkage and use of nmr analyses of the same
11/21/2013	US20130310544 Screening Method for Substance Having Hemocyte Maturation Acceleration Action
11/21/2013	US20130310417 Small Molecules For Endothelial Cell Activation
11/21/2013	US20130310401 Method and kits for determining platelet susceptibility to activation in a patient
11/21/2013	US20130310321 Diagnostic agent for ischemic heart disease risk group
11/21/2013	US20130310315 Method for assessing a subject's risk of having a cardiovascular disease
11/21/2013	US20130310280 Multiplex decoding of array sensors with microspheres
11/21/2013	US20130310278 Multiparameter FACS Assays to Detect Alterations in Cellular Parameters and to Screen Small Molecule Libraries
11/21/2013	US20130310277 Multi-analyte microarrays using tag-specific antibodies and tag-anchored antibodies
11/21/2013	US20130310273 Methods and Means for Diagnosing Vasculitis
11/21/2013	US20130310271 Tuberculosis diagnostic test
11/21/2013	US20130310270 Holographic Imaging for Analyzing Molecules
11/21/2013	US20130310267 Quantitative methods and kits for providing reproducible ihc4 scores
11/21/2013	US20130310266 Methods and Compositions For The Diagnosis And Treatment Of Cancer and Autoimmune Disorders
11/21/2013	US20130309781 Novel adhesive surfaces for the immobilization of ligands
11/21/2013	US20130309779 Optical waveguide measurement system and method for measuring glycated hemoglobin
11/21/2013	US20130309778 Assay device and reader
11/21/2013	US20130309766 Endogenous and Non-Endogenous Versions of Human G Protein-Coupled Receptors
11/21/2013	US20130309760 Assay Device
11/21/2013	US20130309715 Pentamethine cyanine fluorescent dyes, preparation methods and uses thereof
11/21/2013	US20130309713 Pathogen detection systems and methods
11/21/2013	US20130309709 Photouncaging-assisted evaluation of large-scale synaptic reorganization of brain circuits
11/21/2013	US20130309708 Compositions and Methods Useful for Culturing Differentiable Cells
11/21/2013	US20130309698 Methods for Diagnosing Systemic Lupus Erythematosus
11/21/2013	US20130309697 Biomarkers for prostate cancer and methods using the same
11/21/2013	US20130309696 Therapeutic and diagnostic methods for alzheimer's disease
11/21/2013	US20130309695 Methods of diagnosing asthma
11/21/2013	US20130309694 Hybridoma cell line for producing antibody for type ii collagen
11/21/2013	US20130309693 Polypeptides for microbial detection
11/21/2013	US20130309692 Markers for detecting human follicular helper t cells and method for detecting human follicular helper t cells
11/21/2013	US20130309691 Use of heat-resistant biotin-binding protein, and solid support having the protein attached thereto
11/21/2013	US20130309690 Tetrameric alpha-synuclein as biomarkers
11/21/2013	US20130309689 Methods and reagents for biomolecule labeling, enrichment and gentle elution
11/21/2013	US20130309677 In vitro model for pathological or physiologic conditions
11/21/2013	US20130309665 Polymorphisms in the human gene for the multidrug resistance-associated protein 1 (mrp-1) and their use in diagnostic and therapeutic applications
11/21/2013	US20130309664 Heat shock proteins as autoantigens
11/21/2013	US20130309661 Free solution measurement of molecular interactions by backscattering interferometry
11/21/2013	US20130309658 METHOD FOR DETECTING HUMAN PAPILLOMAVIRUS mRNA
11/21/2013	US20130309654 Method of selecting a surface chemistry for culturing a given cell line
11/21/2013	US20130309478 Piece of clothing
11/21/2013	US20130309255 Biomarkers, uses of biomarkers and a method of identifying biomarkers
11/21/2013	US20130309253 Cancer treatment with endothelin receptor antagonists
11/21/2013	US20130309246 Jagged1 as a marker and therapeutic target for breast cancer bone metastasis
11/21/2013	US20130309245 Using a cytokine signature to diagnose disease or infection
11/21/2013	US20130309237 Pathogenic Mycobacteria-Derived Mannose-Capped Lipoarabinomannan Antigen Binding Proteins
11/21/2013	US20130309236 Anti-interferon-alpha antibodies
11/21/2013	US20130309234 Correlation of de novo-induced tumor-associated humoral immune responses with improved clinical outcome
11/21/2013	US20130309232 Vascular endothelial growth factor 2
11/21/2013	US20130309206 Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues
11/21/2013	US20130309194 Inhibition of il-17 production
11/21/2013	US20130309173 Methods and compositions for maintenance of a functional wound
11/21/2013	US20130309145 Method and a device for treating microparticles
11/21/2013	US20130309138 Preservation System for Consumables and Cosmetic Substances
11/21/2013	US20130309134 Portable detection system for allergic diseases
11/21/2013	US20130309133 Analysis cartridge and analysis system thereof
11/21/2013	US20130308831 Method And System For Estimating Rock Properties From Rock Samples Using Digital Rock Physics Imaging
11/21/2013	US20130308823 Method For Quantitatively Determining Eyelash Clumping
11/21/2013	US20130306492 Method and apparatus for assay of electrochemical properties
11/21/2013	US20130305847 System and Method for Inspection of Soft Goods
11/21/2013	US20130305813 Sublimable aromatic compound removing unit for process gas analyzing device, and process gas analyzing device including the same
11/21/2013	US20130305811 Gas sensor
11/21/2013	US20130305808 Breath analyzer and detachable alcohol sensor module
11/21/2013	DE112012000904T5 Flüssigkeitsqualitäts-Prüfvorrichtung und mit der Vorrichtung versehener FIiissigkeitsspeichertank Liquid Quality Tester and provided with the device FIiissigkeitsspeichertank
11/21/2013	DE102012009948A1 Verfahren zum spezifischen und quantitativen Nachweis von Antikörpern in einer Probe A process for specific and quantitative detection of antibodies in a sample
11/21/2013	DE102011056273B4 Fluidreservoir für eine Vorrichtung zur Analyse von Patientenproben Fluid reservoir for an apparatus for the analysis of patient samples
11/21/2013	DE102011008024B4 Vorrichtung zur Probenbehandlung Apparatus for sample treatment
11/21/2013	DE102004057503B4 Diagnosesystem zum Ermitteln von Stoffkonzentrationen in flüssigen Proben Diagnostic system for determining concentrations of substances in liquid samples
11/21/2013	DE102004043153B4 Erfindung betreffend GLP-1 und Exendin Invention concerning GLP-1 and exendin
11/20/2013	EP2665009A1 Nucleic acid information processing device and processing method thereof
11/20/2013	EP2664923A2 Biomarkers for central nervous system diseases
11/20/2013	EP2664922A1 Method for prediction of prognosis of sepsis
11/20/2013	EP2664921A1 Assay
11/20/2013	EP2664920A1 Dilution based inhibition assay
11/20/2013	EP2664919A1 A method for identifying the AhR receptor ligands having a therapeutic sebosuppressive activity
11/20/2013	EP2664918A1 Breath analyzer and detachable alcohol sensor module
11/20/2013	EP2664680A1 Antibody-based methods of diagnosing infections with lymphocytic choriomeningitis virus (LCMV)
11/20/2013	EP2664666A2 Devices and methods for enrichment and alteration of cells and other particles
11/20/2013	EP2664625A2 Blood-brain barrier permeable peptide compositions
11/20/2013	EP2664619A1 Purine derivatives as tools for screening anti-Alzheimer compounds
11/20/2013	EP2664599A1 Ceramics paste and laminate
11/20/2013	EP2664381A1 Analysis cartridge

1 ... 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 ... 3937